™LenticlairT-ON: An extension trial examining long-term safety and efficacy outcomes associated with an inhaled F/HN-pseudotyped lentiviral vector for CF gene therapy in people with CF
Davies JC., Mall MA., Polineni D., Donaldson SH., Fajac I., Jain R., Rubin BK., Boyd AC., Gill DR., Griesenbach U., Hyde SC., McLachlan G., Kohlbrenner V., Sigmund R., Engel AT., Gupta A., Alton EWFW.